DIVIDEND ANNOUNCEMENT: S&P Pharmaceuticals ETF/SPDR Series Trust (NYSE:XPH) on 09/15/2023 declared a dividend of $0.1201 per share

S&P Pharmaceuticals ETF/SPDR Series Trust (NYSE:XPH) on 09/15/2023 declared a dividend of $ 0.1201 per share payable on September 21, 2023 to shareholders of record as of September 19, 2023. Dividend amount recorded is a decrease of $ 0.0034 from last dividend Paid.

S&P Pharmaceuticals ETF/SPDR Series Trust (NYSE:XPH) has paid dividends since 2007, has a current dividend yield of 1.3056657314% and has increased its dividends for 2 successive years.

S&P Pharmaceuticals ETF/SPDR Series Trust's market cap is $ 634,772,000 and has a PE ratio of 0.00. The stock price closed yesterday at $ 42.89 and has a 52 week low/high of $ 38.94 and $ 44.31.

SPDR S&P Pharmaceuticals is an open-end investment management company. The Fund seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. As of June 30 2015, the Fund's total assets and investment portfolio totaled $1,324,794,738 and $1,323,892,831, respectively.

For more information on S&P Pharmaceuticals ETF/SPDR Series Trust click here.